[특허]Dry powder fibrin sealant

Dry powder fibrin sealant 원문보기

IPC분류정보
국가/구분	United States(US) Patent 등록
국제특허분류(IPC7판)	A61K-038/48 A61K-009/14 A61K-038/36 A61K-009/50 A61K-009/16
출원번호	US-0636718 (2009-12-12)
등록번호	US-9827205 (2017-11-28)
발명자 / 주소	Whitfield, Nicola Koopman, Jaap Grimbergen, Jos
출원인 / 주소	Mallinckrodt Pharma IP Trading D.A.C.
인용정보	피인용 횟수 : 0 인용 특허 : 54

초록

The invention provides a composition comprising a mixture of first microparticles that comprise fibrinogen and trehalose, and second microparticles that comprise thrombin and trehalose. The invention further provides methods for treating wounds by administering the novel microparticle composition.

대표청구항 ▼

1. A dry powder fibrin sealant composition, comprising: a mixture of first microparticles that comprise fibrinogen and trehalose, andsecond microparticles that comprise thrombin and trehalose,wherein trehalose is the only stabilizing sugar in the first microparticles and second microparticles, andwherein the concentration of trehalose in the first microparticles is sufficient to preserve at least 70% of fibrinogen activity after exposure of the first microparticles to a 25 kGy dose of gamma irradiation delivered at a rate of 8 kGy/hour. 2. The composition of claim 1, wherein fibrinogen activity is measured by ELISA. 3. The composition of claim 1, wherein fibrinogen activity is measured by clot strength assay. 4. The composition of claim 1, wherein fibrinogen activity is measured by ELISA and clot strength assay. 5. The composition of claim 1, wherein the concentration of trehalose in the first microparticles and second microparticles is sufficient to preserve at least 70% of expected clot strength after exposure of the mixture of microparticles to a 25 kGy dose of gamma irradiation delivered at a rate of 8 kGy/hour. 6. The composition according to claim 1 or claim 5, wherein said first microparticles contain 0.5 to 20% w/w fibrinogen. 7. The composition of claim 6, wherein said second microparticles comprise 10 to 20,000 IU/g thrombin. 8. The composition of claim 7, wherein said second microparticles comprise 25 to 1,000 IU/g thrombin. 9. The composition of claim 1 or 5, wherein said microparticles are spray-dried microparticles. 10. The composition of claim 9, wherein the composition has a residual moisture content no greater than 5% (w/w). 11. The composition of claim 10, wherein the residual content is no great than 3% (w/w). 12. The composition of claim 1 or claim 5, wherein said first and second microparticles are mixed in a weight ratio of 1:1. 13. A method of treating a wound, comprising administering to the wound an effective amount of the composition as defined in claim 1. 14. The method, as claimed in claim 13, further comprising the step of applying pressure immediately after said administering. 15. The dry powder fibrin sealant composition of claim 1, wherein the composition is sterilizable. 16. A method for preparing a dry powder fibrin sealant composition comprising a mixture of first microparticles that comprise fibrinogen and trehalose and second microparticles that comprise thrombin and trehalose, wherein trehalose is the only stabilizing sugar in the first microparticles and second microparticles, the method comprising: (i) spray-drying a first aqueous solution comprising fibrinogen and trehalose to produce said first microparticles, wherein said first aqueous solution does not include a second stabilizing sugar and the concentration of trehalose in the first microparticles is sufficient to preserve at least 70% of fibrinogen activity after exposure of the first microparticles to a 25 kGy dose of gamma irradiation delivered at a rate of 8 kGy/hour;(ii) spray-drying a second aqueous solution comprising thrombin and trehalose to produce said second microparticles, wherein said second aqueous solution does not include a second stabilizing sugar; and(iii) mixing the first and second microparticles. 17. The method of claim 16, wherein the concentration of trehalose in each of the first and second microparticles is sufficient to preserve at least 70% of expected clot strength after exposure of the mixture of microparticles to a 25 kGy dose of gamma irradiation delivered at a rate of 8 kGy/hour. 18. The method of claim 16 or claim 17, wherein said first microparticles contain 0.5 to 20% w/w fibrinogen. 19. The method of claim 16 or claim 17, wherein said second microparticles comprise 10 to 20,000 IU/g thrombin. 20. The method of claim 19, wherein said second microparticles comprise 25 to 1,000 IU/g thrombin. 21. The method of claim 16 or claim 17, wherein each of the first and second aqueous solutions is spray-dried with an outlet temperature of at least about 80° C. 22. The method of claim 21, wherein the dry powder fibrin sealant composition has a residual moisture content no greater than 5% (w/w). 23. The method of claim 22, wherein each of the first and second aqueous solutions is spray-dried with an outlet temperature of at least about 83° C. 24. The method of claim 22, wherein the residual moisture content is no greater than 3% (w/w). 25. The method of claim 16 or claim 17, wherein step (iii) comprises mixing the first and second microparticles in a weight ratio of 1:1.

이 특허에 인용된 특허 (54)

Gertner, Michael E., Aerosol device to deliver bioactive agent.
상세보기
Ferdman Ariel G. ; Pinsky Vladimir J., Apparatus and method for applying a particulate hemostatic agent to living tissue.
상세보기
Sutton Andrew Derek,GBX ; Johnson Richard Alan,GBX, Cross-linked microparticles and their use as therapeutic vehicles.
상세보기
Platz,Robert M.; Patton,John S.; Foster,Linda; Eljamal,Mohammed, Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments.
상세보기
Platz Robert M. ; Brewer Thomas K. ; Boardman Terence D., Dispersible macromolecule compositions and methods for their preparation and use.
상세보기
Platz, Robert M.; Brewer, Thomas K.; Boardman, Terence D., Dispersible macromolecule compositions and methods for their preparation and use.
상세보기
Platz,Robert; Brewer,Thomas; Boardman,Terrence, Dispersible macromolecule compositions and methods for their preparation and use.
상세보기
Robert M. Platz ; Thomas K. Brewer ; Terence D. Boardman, Dispersible macromolecule compositions and methods for their preparation and use.
상세보기
Stroetmann Michael (Mnster DEX), Enriched plasma derivative for advancement of wound closure and healing.
상세보기
Stroetmann Michael (Mnster DEX), Enriched plasma derivative for enhancement of wound closure and coverage.
상세보기
Rapp, Mirna; Prasch, Armin; Luy, Bernhard, Fibrin adhesive granulate and method for its preparation.
상세보기
Stroetmann Michael (Mnster DEX), Fibrinogen-containing dry preparation, manufacture and use thereof.
상세보기
Coury Arthur J. ; Sawhney Amarpreet S. ; Hubbell Jeffrey A.,CHX ; Philbrook C. Michael, Hemostatic tissue sealants.
상세보기
Roser Bruce J. (Balsham GB2) Colaco Camilo (Trumpington GB2), Method of preserving agarose gel structure during dehydration by adding a non-reducing glycoside of a straight-chain sug.
상세보기
Devore Dale P. ; Putnam Charles ; Pachence James M., Methods and products for sealing a fluid leak in a tissue.
상세보기
Miekka, Shirley I.; Burgess, Wilson; Drohan, William N.; Griko, Yuri; MacPhee, Martin J.; Mann, David M., Methods for sterilizing biological materials.
상세보기
Drohan,William N.; MacPhee,Martin J.; Nunez,Hernan; Liau,Gene; Maciag,Thomas; Burgess,Wilson H., Methods for treating wound tissue and forming a supplemented fibrin matrix.
상세보기
Roser, Bruce J.; Colaco, Camilo; Kampinga, Jaap; Smith, Christopher, Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby.
상세보기
Kampinga, Jaap; Alcock, Robert A., Methods of terminal sterilization of fibrinogen.
상세보기
Cheryl Vanessa Rogerson GB; Nicholas David Osborne GB, Microparticles and their therapeutic or diagnostic use.
상세보기
Heath David,GBX ; Middleton Sarah Margaret,GBX, Microparticles and their use in wound therapy.
상세보기
Sutton Andrew D. (Ruddington GB2) Johnson Richard A. (West Bridgford GB2) Senior Peter J. (Near Melbourne GB2) Heath David (The Park GB2), Preparation of diagnostic agents.
상세보기
Sutton Andrew D.,GBX ; Johnson Richard A.,GBX ; Senior Peter J.,GBX ; Heath David,GBX, Preparation of diagnostic agents.
상세보기
Sutton, Andrew D.; Johnson, Richard A.; Senior, Peter J.; Heath, David, Preparation of diagnostic agents.
상세보기
Andrew Derek Sutton GB; Richard Alan Johnson GB, Preparation of diagnostic agents by spray drying.
상세보기
Andrew Derek Sutton GB; Richard Alan Johnson GB, Preparation of further diagnostic agents.
상세보기
Andrew Derek Sutton GB; Richard Alan Johnson GB, Preparation of further diagnostic agents.
상세보기
Sutton Andrew Derek,GBX ; Johnson Richard Alan,GBX, Preparation of further diagnostic agents.
상세보기
Sutton Andrew Derek,GBX ; Johnson Richard Alan,GBX, Preparation of further diagnostic agents.
상세보기
Sutton, Andrew Derek; Johnson, Richard Alan, Preparation of further diagnostic agents.
상세보기
Osborne Nicholas,GBX ; Sutton Andrew Derek,GBX ; Johnson Richard Alan,GBX, Preparation of hollow microcapsules by spray-drying an aqueous solution of a wall-forming material and a water-miscible.
상세보기
Roser Bruce J. (Balsham GB3), Protection of proteins and the like.
상세보기
Roser Bruce J.,GBX ; Kampinga Jaap,NLX ; Colaco Camilo,GBX ; Blair Julian,GBX, Solid dose delivery vehicle and methods of making same.
상세보기
Roser Bruce J.,GBX ; Kampinga Jaap,NLX ; Colaco Camilo,GBX ; Blair Julian,GBX, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Roser,Bruce J.; Kampinga,Jaap; Colaco,Camilo; Blair,Julian, Solid dose delivery vehicle and methods of making same.
상세보기
Platz, Robert M.; Patton, John S.; Foster, Linda; Eljamal, Mohammed, Spray drying of macromolecules to produce inhaleable dry powders.
상세보기
Sutton Andrew D.,GBX ; Johnson Richard A.,GBX ; Senior Peter J.,GBX ; Heath David,GBX, Spray-dried microparticles and their use as therapeutic vehicles.
상세보기
Sutton, Andrew D.; Johnson, Richard A.; Senior, Peter J.; Heath, David, Spray-dried microparticles and their use as therapeutic vehicles.
상세보기
Osborne, Nicholas; Sutton, Andrew Derek; Johnson, Richard Alan, Spray-drying microcapsules using an aqueous liquid containing a volatile liquid.
상세보기
Foster Linda C. ; Kuo Mei-chang ; Billingsley Sheila R., Stable glassy state powder formulations.
상세보기
Foster Linda C. ; Kuo Mei-chang ; Billingsley Shelia R., Stable glassy state powder formulations.
상세보기
Foster, Linda C.; Kuo, Mei-chang; Billingsley, Shelia R., Stable glassy state powder formulations.
상세보기
MacPhee Martin James ; Drohan William Nash ; Liau Gene ; Haudenschild Christian, Supplemented and unsupplemented tissue sealants, method of their production and use.
상세보기
MacPhee Martin James ; Drohan William Nash ; Woolverton Christoper J., Supplemented and unsupplemented tissue sealants, methods of their production and use.
상세보기
MacPhee,Martin James; Drohan,William Nash; Liau,Gene; Nunez,Hernan; Burgess,Wilson H.; Maciag,Thomas, Supplemented and unsupplemented tissue sealants, methods of their production and use.
상세보기
Drohan,William N.; MacPhee,Martin J.; Nunez,Hernan; Liau,Gene; Burgess,Wilson H.; Maciag,Thomas, Supplemented fibrin matrix delivery systems.
상세보기
Saferstein Lowell (Edison NJ) Wolf Stephen J. (Manville NJ), Thrombin aerosol.
상세보기
Bar, Lily; Nur, Israel, Use of fibrinogen multimers.
상세보기

IPC	Description
A	생활필수품
A62	인명구조; 소방(사다리 E06C)
A62B	인명구조용의 기구, 장치 또는 방법(특히 의료용에 사용되는 밸브 A61M 39/00; 특히 물에서 쓰이는 인명구조 장치 또는 방법 B63C 9/00; 잠수장비 B63C 11/00; 특히 항공기에 쓰는 것, 예. 낙하산, 투출좌석 B64D; 특히 광산에서 쓰이는 구조장치 E21F 11/00)
A62B-1/08	.. 윈치 또는 풀리에 제동기구가 있는 것

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표IPC 관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 공고번호, 공고일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표출원인, 출원인국적, 출원인주소, 발명자, 발명자E, 발명자코드, 발명자주소, 발명자 우편번호, 발명자국적, 대표IPC, IPC코드, 요약, 미국특허분류, 대리인주소, 대리인코드, 대리인(한글), 대리인(영문), 국제공개일자, 국제공개번호, 국제출원일자, 국제출원번호, 우선권, 우선권주장일, 우선권국가, 우선권출원번호, 원출원일자, 원출원번호, 지정국, Citing Patents, Cited Patents
저장형식	Text(ASCII format) Excel format PIAS분석(.xls)
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Dry powder fibrin sealant 원문보기

초록

대표청구항 ▼

연구과제 타임라인

이 특허에 인용된 특허 (54)

관련 콘텐츠

특허 원문 보기

IPC 상위 출원인

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

Dry powder fibrin sealant 원문보기

초록

대표청구항 ▼

연구과제 타임라인

전체(0) 논문(0) 특허(0) 보고서(0)

전체(0) 논문(0) 특허(0) 보고서(0)

이 특허에 인용된 특허 (54)

관련 콘텐츠

특허 원문 보기

IPC 상위 출원인

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트